Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays;Transkriptomanalysen beim nierenzellkarzinom. Kombination von lasermikrodissektion und microarrays

Urologe - Ausgabe A

Volumn 46, Issue 9, 2007, Pages 1170-1175

  Buchner, A ^a   Castro, M ^a   Hennig, A ^a   Popp, T ^a   Assmann, G ^b   Hofstetter, A ^a   Stief, C ^a   Zimmermann, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Expression analysis; Laser microdissection; Microarray; Renal cell carcinoma; Transcriptome

Indexed keywords

RNA;

ARTICLE; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; GENE CONTROL; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; HUMAN; KIDNEY CARCINOMA; LASER MICRODISSECTION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; UPREGULATION; VALIDATION PROCESS;

CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LASERS; MICRODISSECTION; NEPHRECTOMY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 34648834790     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1473-8     Document Type: Article

References (26)

1. Ashburner M, Ball CA, Blake JA et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29
2. Atzpodien J, Kirchner H, Illiger HJ et al. (2001) IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. Br J Cancer 85: 1130-1136
3. Boer JM, Huber WK, Sultmann H et al. (2001) Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11: 1861-1870
4. Bonner RF, Emmert-Buck M, Cole K et al. (1997) Laser capture microdissection: molecular analysis of tissue. Science 278: 1481-1483
5. Escudier B, Eisen T, Stadler WM et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125-134
6. Gitlitz BJ, Figlin RA (2003) Cytokine-based therapy for metastatic renal cell cancer. Urol Clin North Am 30: 589-600
7. Goto Y, Matsuzaki Y, Kurihara S et al. (2006) A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. Cancer Res 66: 4443-4449
8. Hergenhahn M, Kenzelmann M, Grone HJ (2003) Laser-controlled microdissection of tissues opens a window of new opportunities. Pathol Res Pract 199: 419-423
9. Janzen NK, Kim HL, Figlin RA, Belldegrun AS (2003) Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30: 843-852
10. Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA (2005) G250: a carbonic anhydrase IX monoclonal antibody. Curr Oncol Rep 7: 109-115
11. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36
12. Lockhart DJ, Winzeler EA (2000) Genomics, gene expression and DNA arrays. Nature 405: 827-836
13. Luo L, Salunga RC, Guo H et al. (1999) Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 5: 117-122
14. Luzzi V, Mahadevappa M, Raja R et al. (2003) Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn 5: 9-14
15. McGall G, Labadie J, Brock P et al. (1996) Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists. Proc Natl Acad Sci USA 93: 13555-13560
16. McLaughlin JK, Lipworth L, Tarone RE (2006) Epidemiologic aspects of renal cell carcinoma. Semin Oncol 33: 527-533
17. Motzer RJ, Hutson TE, Tomczak P et al. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356: 115-124
18. Scheidl SJ, Nilsson S, Kalen M et al. (2002) mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am J Pathol 160: 801-813
19. Shedden K, Chen W, Kuick R et al. (2005) Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data. BMC Bioinfo 6: 26
20. Simone NL, Bonner RF, Gillespie JW et al. (1998) Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 14: 272-276
21. Skubitz KM, Skubitz AP (2002) Differential gene expression in renal-cell cancer. J Lab Clin Med 140: 52-64
22. Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours. 6th edn. Wiley & Sons, New York
23. Takahashi M, Rhodes DR, Furge KA et al. (2001) Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 98: 9754-9759
24. Vasselli JR, Shih JH, Iyengar SR et al. (2003) Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci USA 100: 6958-6963
25. Weinschenk T, Gouttefangeas C, Schirle M et al. (2002) Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res 62: 5818-5827
26. Young AN, Amin MB, Moreno CS et al. (2001) Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 158: 1639-1651